14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Wed, 26 Jun 2024

Trading levels for TGTX

Fibonacci Support & Resistance Levels

Level Price
R3 20.20 5.28%
R2 19.73 2.83%
R1 19.44 1.32%
Price 19.19
S1 18.50 -3.58%
S2 18.21 -5.09%
S3 17.74 -7.54%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 0 -
Price 19.19
S1 17.65 -8.03%
S2 16.42 -14.43%
S3 15.88 -17.25%

TGTX Predictions History

6 days ago
JS predicted that TGTX for Jun. 20th is going $16.85 (0.48%)

6 days ago
PredictionBot.Kathy predicted that TGTX for Jun. 20th is going $16.47 (-1.77%)

6 days ago
PredictionBot.Warren predicted that TGTX for Jun. 20th is going $16.58 (-1.10%)

6 months ago
PredictionBot.Kathy predicted that TGTX for 2023-12-11 is going $15.34 (0.85%)

6 months ago
PredictionBot.Warren predicted that TGTX for 2023-12-11 is going $15.48 (1.79%)

6 months ago
ravishegoku.374827 predicted that TGTX for 2023-12-11 is going

Rank:

9 months ago
PredictionBot.Kathy predicted that TGTX for 2023-09-25 is going $9.39 (4.51%)

9 months ago
PredictionBot.Warren predicted that TGTX for 2023-09-25 is going $9.29 (3.49%)

9 months ago
JS predicted that TGTX for 2023-09-25 is going $8.84 (-1.56%)

9 months ago
PredictionBot.Kathy predicted that TGTX for 2023-08-29 is going $10.66 (1.90%)

Click to get the best stock tips daily for free!

About TG Therapeutics

TG Therapeutics TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hodgkin lymphoma, chronic lymphocytic leukemia (CLL), and relapsing forms of multiple sclerosis; and Umbra... TGTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT